These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18071630)

  • 21. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.
    Havanka H; Dahlöf C; Pop PH; Diener HC; Winter P; Whitehouse H; Hassani H
    Clin Ther; 2000 Aug; 22(8):970-80. PubMed ID: 10972633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
    Ashcroft DM; Millson D
    Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case Report: Rizatriptan-Induced Ischemic Colitis.
    Fonseka GR; Kurchin A
    Headache; 2015; 55(7):1008-9. PubMed ID: 25881718
    [No Abstract]   [Full Text] [Related]  

  • 25. Pure naratriptan-induced ischemic colitis: a case report.
    Westgeest HM; Akol H; Schreuder TC
    Turk J Gastroenterol; 2010 Mar; 21(1):42-4. PubMed ID: 20533112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptans in pregnancy.
    Soldin OP; Dahlin J; O'Mara DM
    Ther Drug Monit; 2008 Feb; 30(1):5-9. PubMed ID: 18223456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of naratriptan and prochlorperazine in migraine treatment.
    Tietjen GE; Athanas K; Utley C; Herial NA; Khuder SA
    Headache; 2005 Jun; 45(6):751-3. PubMed ID: 15953309
    [No Abstract]   [Full Text] [Related]  

  • 28. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 29. Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
    Sheftell FD; Rapoport AM; Tepper SJ; Bigal ME
    Headache; 2005; 45(10):1400-6. PubMed ID: 16324173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naratriptan.
    Salonen R
    Int J Clin Pract; 1999; 53(7):552-6. PubMed ID: 10692743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Naratriptan. A new medical option for the pharmacist].
    Kunkel M
    Med Monatsschr Pharm; 2007 May; 30(5):184-6. PubMed ID: 17526395
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral naratriptan approved for migraine attacks.
    Am J Health Syst Pharm; 1998 Apr; 55(7):638. PubMed ID: 9558416
    [No Abstract]   [Full Text] [Related]  

  • 33. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.
    Klassen A; Elkind A; Asgharnejad M; Webster C; Laurenza A
    Headache; 1997; 37(10):640-5. PubMed ID: 9439085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myalgia and cramps associated with zolmitriptan.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2005; 28(5):241-2. PubMed ID: 16239765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximum effect of triptans in migraine? A comment.
    Tfelt-Hansen P
    Cephalalgia; 2008 Jul; 28(7):767-8. PubMed ID: 18547214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence.
    Sheftell F; O'Quinn S; Watson C; Pait D; Winter P
    Headache; 2000 Feb; 40(2):103-10. PubMed ID: 10759909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.
    Stark S; Spierings EL; McNeal S; Putnam GP; Bolden-Watson CP; O'Quinn S
    Headache; 2000; 40(7):513-20. PubMed ID: 10940089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
    Berenson F; Vasconcellos E; Pakalnis A; Mao L; Biondi DM; Armstrong RB
    Headache; 2010 May; 50(5):795-807. PubMed ID: 20546320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: "Naratriptan in the prophylaxis of transformed migraine" (Sheftell FD Rapoport AM, Coddon DR. Headache.1999,39:506-510).
    Warner JS
    Headache; 2000 Mar; 40(3):252. PubMed ID: 10970177
    [No Abstract]   [Full Text] [Related]  

  • 40. Rizatriptan-Induced Colonic Ischemia: A Case Report and Literature Review.
    Dieringer TD; Crossland DM; Mahl TC
    Am J Gastroenterol; 2018 Jan; 113(1):148-149. PubMed ID: 29311721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.